胃肠激素在记忆调节中的作用研究进展(3)
[4]Moon M，Choi JG，Nam DW，et al.Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-β1-42 oligomer-injected mice[J].Journal of Alzheimers Disease Jad，2011，23(1)：147.
[5]Morgan AH，Rees DJ，Andrews ZB，et al.Ghrelin mediated neuroprotection -A possible therapy for Parkinson's disease[J].Neuropharmacology，2017(12)：23.
[6]Zhao Z，Liu H，Xiao K，et al.Ghrelin administration enhances neurogenesis but impairs spatial learning and memory in adult mice[J].Neuroscience，2014，257(C)：175-185.
, 百拇医药
[7]Hlscher C.Potential Role of Glucagon-Like Peptide-1 (GLP-1)in Neuroprotection[J].Cns Drugs，2012，26(10)：871-882.
[8]Gault V A，Hlscher C.GLP-1 receptor agonists show neuroprotective effects in animal models of diabetes[J].Peptides，2018(100)：101-107.
[9]Cai XS，Tan ZG，Li JJ，et al.Glucagon-Like Peptide-1 (GLP-1)Treatment Ameliorates Cognitive Impairment by Attenuating Arc Expression in Type 2 Diabetic Rats[J].Medical Science Monitor International Medical Journal of Experimental &Clinical Research，2017(23)：4334.
, 百拇医药
[10]Abbas T，Faivre E，Hlscher C.Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice：Interaction between type 2 diabetes and Alzheimer's disease[J].Behavioural Brain Research，2009，205(1)：265-271.
[11]Wang Y，Chen S，Xu Z，et al.GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling[J].Neuropharmacology，2017(131)：190-199.
, http://www.100md.com [12]Mcguire MJ，Ishii M.Leptin Dysfunction and Alzheimer's Disease：Evidence from Cellular，Animal，and Human Studies[J].Cellular&Molecular Neurobiology，2016，36(2)：203.
[13]Magalhes CA，Carvalho MG，Sousa LP，et al.Leptin in Alzheimer's disease[J].Clinica Chimica Acta，2015(450)：162-168.
[14]Anastasi A，Erspamer V，Bucci M.Isolation and structure of bombesin and alytesin，2 analogous active peptides from the skin of the European amphibians Bombina and Alytes[J].Experientia，1971，27(2)：166-167.
, http://www.100md.com
[15]Marchezan J，Becker M，Schwartsmann G，et al.A Placebo-Controlled Crossover Trial of Gastrin-Releasing Peptide in Childhood Autism[J].Clinical Neuropharmacology，2019，40(3)：108.
[16]Roesler R，Kent P，Schroder N，et al.Bombesin receptor regulation of emotional memory[J].Reviews in the Neurosciences，2012，23(5-6)：571-586.
[17]Murkar A，Kent P，Cayer C，et al.Gastrin-Releasing Peptide attenuates fear memory reconsolidation[J].Behavioural Brain Research，2018(16)：347：255-262.
, 百拇医药
[18]Yang J，Yao Y，Wang L，et al.Gastrin-releasing peptide facilitates glutamatergic transmission in the hippocampus and effectively prevents vascular dementia induced cognitive and synaptic plasticity deficits[J].Experimental Neurology，2017，287(Pt 1)：75-83.
[19]Yao Y，Wang F，Yang X，et al.Bombesin attenuated ischemia-induced spatial cognitive and synaptic plasticity impairment associated with oxidative damage.[J].Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie，2018(103)：87-93.
收稿日期：2018-5-22；修回日期：2018-5-31
編辑/雷华, http://www.100md.com(姚扬 杨佳佳 汪志云)
[5]Morgan AH，Rees DJ，Andrews ZB，et al.Ghrelin mediated neuroprotection -A possible therapy for Parkinson's disease[J].Neuropharmacology，2017(12)：23.
[6]Zhao Z，Liu H，Xiao K，et al.Ghrelin administration enhances neurogenesis but impairs spatial learning and memory in adult mice[J].Neuroscience，2014，257(C)：175-185.
, 百拇医药
[7]Hlscher C.Potential Role of Glucagon-Like Peptide-1 (GLP-1)in Neuroprotection[J].Cns Drugs，2012，26(10)：871-882.
[8]Gault V A，Hlscher C.GLP-1 receptor agonists show neuroprotective effects in animal models of diabetes[J].Peptides，2018(100)：101-107.
[9]Cai XS，Tan ZG，Li JJ，et al.Glucagon-Like Peptide-1 (GLP-1)Treatment Ameliorates Cognitive Impairment by Attenuating Arc Expression in Type 2 Diabetic Rats[J].Medical Science Monitor International Medical Journal of Experimental &Clinical Research，2017(23)：4334.
, 百拇医药
[10]Abbas T，Faivre E，Hlscher C.Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice：Interaction between type 2 diabetes and Alzheimer's disease[J].Behavioural Brain Research，2009，205(1)：265-271.
[11]Wang Y，Chen S，Xu Z，et al.GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling[J].Neuropharmacology，2017(131)：190-199.
, http://www.100md.com [12]Mcguire MJ，Ishii M.Leptin Dysfunction and Alzheimer's Disease：Evidence from Cellular，Animal，and Human Studies[J].Cellular&Molecular Neurobiology，2016，36(2)：203.
[13]Magalhes CA，Carvalho MG，Sousa LP，et al.Leptin in Alzheimer's disease[J].Clinica Chimica Acta，2015(450)：162-168.
[14]Anastasi A，Erspamer V，Bucci M.Isolation and structure of bombesin and alytesin，2 analogous active peptides from the skin of the European amphibians Bombina and Alytes[J].Experientia，1971，27(2)：166-167.
, http://www.100md.com
[15]Marchezan J，Becker M，Schwartsmann G，et al.A Placebo-Controlled Crossover Trial of Gastrin-Releasing Peptide in Childhood Autism[J].Clinical Neuropharmacology，2019，40(3)：108.
[16]Roesler R，Kent P，Schroder N，et al.Bombesin receptor regulation of emotional memory[J].Reviews in the Neurosciences，2012，23(5-6)：571-586.
[17]Murkar A，Kent P，Cayer C，et al.Gastrin-Releasing Peptide attenuates fear memory reconsolidation[J].Behavioural Brain Research，2018(16)：347：255-262.
, 百拇医药
[18]Yang J，Yao Y，Wang L，et al.Gastrin-releasing peptide facilitates glutamatergic transmission in the hippocampus and effectively prevents vascular dementia induced cognitive and synaptic plasticity deficits[J].Experimental Neurology，2017，287(Pt 1)：75-83.
[19]Yao Y，Wang F，Yang X，et al.Bombesin attenuated ischemia-induced spatial cognitive and synaptic plasticity impairment associated with oxidative damage.[J].Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie，2018(103)：87-93.
收稿日期：2018-5-22；修回日期：2018-5-31
編辑/雷华, http://www.100md.com(姚扬 杨佳佳 汪志云)